Release Date: 31/08/10 15:20 Summary: Half Yearly Report and Accounts Price Sensitive: Yes Download Document 1.33MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%